Medidata Designer Wins Bio-IT World Best of Show
Medidata’s clinical protocol authoring and trial design tool takes top honors in clinical trial and research category.
New York, NY-May 2, 2008-Medidata Solutions (www.mdsol.com), a global provider of clinical trial technology, today announced that Medidata Designer™ has been selected as the winner of Bio-IT World magazine’s Best of Show award in the Clinical Trials and Research category. Medidata Designer was chosen from a group of more than 30 companies in the clinical technology space and was honored at the Bio-IT World Conference and Expo, held April 28–30, 2008, in Boston, MA.
“Medidata Designer emerged as the clear leader in the Clinical Trials and Research category in this year?s competition,” said Stephen Fogelson, president of Develotron LLC and one of the judges for the Best of Show awards. “While we received and reviewed a number of impressive submissions, Medidata Designer stood out from the rest due to its ability to bring significant value to clinical researchers by eliminating inconsistency errors and improving the overall quality of clinical protocols.”
A top recognition in the life sciences space, this award demonstrates Medidata’s commitment to advancing clinical trial solutions through innovative technology. As an electronic protocol authoring tool, Medidata Designer captures both the textual description of a study as well as a structured, electronic model of the trial specifications that can be leveraged downstream in clinical and operational study management and design. The product brings better quality, consistency and control to the protocol authoring process and delivers tangible benefits to medical writers, clinicians, and statisticians who author the protocol and other associated study documents. Furthermore, Medidata Designer can automatically configure other clinical trial systems-such as electronic data capture (EDC), clinical trial management (CTMS), electronic patient reported outcomes (ePRO), data analysis, and electronic data submissions-ensuring an automated environment for consistent, shared clinical and operational requirements.
“We are thrilled to have been selected as a Best of Show award winner and recognized as one of the most innovative clinical trial technology organizations in the industry,” said Ed Seguine, general manager of trial planning solutions at Medidata Solutions. “The selection of Medidata Designer as a Best of Show winner emphasizes our development team’s dedication to providing life science companies with the tools they need to drive significant efficiencies across the clinical trial process and for all members of the clinical research team.”
The Best of Show awards program is judged by a team of Bio-IT World magazine editors and leading industry experts and spotlights new products that demonstrate exceptional technology innovation across the life sciences research, discovery, and clinical trials process. Winners were chosen among entries submitted from leading bio-IT vendors exhibiting at the annual conference and expo, based on the products’ technical merit, functionality, and innovation. Finalists were chosen from seven categories, including Clinical Trials and Research, Basic Research/R&D, Drug Discovery & Development, Translational & Personalized Medicine, Business & Economic Development, IT Infrastructure/Knowledge Management, and Chemistry & Compounds.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
